O'Driscoll L - Search Results

1

Expression and prognostic relevance of Mcl-1 in breast cancer.

O'Driscoll L, Cronin D, Kennedy SM, Purcell R, Linehan R, Glynn S, Larkin A, Scanlon K, McDermott EW, Hill AD, O'Higgins NJ, Parkinson M, Clynes M. O'Driscoll L, et al. Anticancer Res. 2004 Mar-Apr;24(2A):473-82. Anticancer Res. 2004. PMID: 15152946 Free article.

2

Design, synthesis and biological evaluation of a novel bioactive indane scaffold 2-(diphenylmethylene)c-2,3-dihydro-1H-inden-1-one with potential anticancer activity.

Zhang T, Bandero V, Corcoran C, Obaidi I, Ruether M, O'Brien J, O'Driscoll L, Frankish N, Sheridan H. Zhang T, et al. Among authors: o driscoll l. Eur J Pharm Sci. 2023 Sep 1;188:106529. doi: 10.1016/j.ejps.2023.106529. Epub 2023 Jul 17. Eur J Pharm Sci. 2023. PMID: 37459901 Free article.

3

Doxorubicin Loading into Milk and Mesenchymal Stem Cells' Extracellular Vesicles as Drug Delivery Vehicles.

Mukhopadhya A, Tsiapalis D, McNamee N, Talbot B, O'Driscoll L. Mukhopadhya A, et al. Pharmaceutics. 2023 Feb 21;15(3):718. doi: 10.3390/pharmaceutics15030718. Pharmaceutics. 2023. PMID: 36986579 Free PMC article.

4

Therapeutic Effects of Mesenchymal/Stromal Stem Cells and Their Derived Extracellular Vesicles in Rheumatoid Arthritis.

Tsiapalis D, Floudas A, Tertel T, Boerger V, Giebel B, Veale DJ, Fearon U, O'Driscoll L. Tsiapalis D, et al. Among authors: o driscoll l. Stem Cells Transl Med. 2023 Dec 18;12(12):849-862. doi: 10.1093/stcltm/szad065. Stem Cells Transl Med. 2023. PMID: 37934808 Free PMC article.

5

The use of reverse transcriptase-polymerase chain reaction (RT-PCR) to investigate specific gene expression in multidrug-resistant cells.

O'Driscoll L, Daly C, Saleh M, Clynes M. O'Driscoll L, et al. Cytotechnology. 1993;12(1-3):289-314. doi: 10.1007/BF00744669. Cytotechnology. 1993. PMID: 7509167 Review.

6

Multiple drug resistance-related messenger RNA expression in archival formalin-fixed paraffin-embedded human breast tumour tissue.

O'Driscoll L, Kennedy S, McDermott E, Kelehan P, Clynes M. O'Driscoll L, et al. Eur J Cancer. 1996 Jan;32A(1):128-33. doi: 10.1016/0959-8049(95)00552-8. Eur J Cancer. 1996. PMID: 8695220

7

mdr1 ribozyme mediated reversal of the multi-drug resistant phenotype in human lung cell lines.

Daly C, Coyle S, McBride S, O'Driscoll L, Daly N, Scanlon K, Clynes M. Daly C, et al. Cytotechnology. 1996;19(3):199-205. doi: 10.1007/BF00744213. Cytotechnology. 1996. PMID: 8862007

8

Isolation from a human MDR lung cell line of multiple clonal subpopulations which exhibit significantly different drug resistance.

Heenan M, O'Driscoll L, Cleary I, Connolly L, Clynes M. Heenan M, et al. Int J Cancer. 1997 May 29;71(5):907-15. doi: 10.1002/(sici)1097-0215(19970529)71:5<907::aid-ijc33>3.0.co;2-1. Int J Cancer. 1997. PMID: 9180164 Free article.

9

Engineering Vero cells to secrete human insulin.

O'Driscoll L, Gammell P, Clynes M. O'Driscoll L, et al. In Vitro Cell Dev Biol Anim. 2002 Mar;38(3):146-53. doi: 10.1290/1071-2690(2002)038<0146:EVCTSH>2.0.CO;2. In Vitro Cell Dev Biol Anim. 2002. PMID: 12026163

10

Galectin-3 expression alters adhesion, motility and invasion in a lung cell line (DLKP), in vitro.

O'Driscoll L, Linehan R, Liang YH, Joyce H, Oglesby I, Clynes M. O'Driscoll L, et al. Anticancer Res. 2002 Nov-Dec;22(6A):3117-25. Anticancer Res. 2002. PMID: 12530054

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

167 results

Search Page